Abstract
(2018). Raltegravir versus lopinavir/ritonavir for treatment of HIV-infected late-presenting pregnant women. HIV Clinical Trials: Vol. 19, No. 3, pp. 94-100.
Funding Information
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Merck (MISP 38735)

This publication has 17 references indexed in Scilit: